Average Co-Inventor Count = 3.53
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Allergan, Inc. (33 from 2,285 patents)
2. Allergan Sales, Inc. (1 from 228 patents)
34 patents:
1. 9758509 - Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitors
2. 9657005 - Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitors
3. 9567324 - Substituted nicotinamide derivatives as kinase inhibitors
4. 9365575 - Kinase inhibitors
5. 9321766 - Kinase inhibitors
6. 9296747 - Piperidylpyrimidine derivatives as modulators of protein kinase inhibitors and of vascular endothelial growth factor receptor 2
7. 9266869 - Substituted dialkyl(oxido)-lambda4-sulfanylidene nicotinamide derivatives as kinase inhibitors
8. 8969583 - 3-phenyl-5-ureidoisothiazole-4-carboximide and 3-amino-5-phenylisothiazole derivatives as kinase inhibitors
9. 8865682 - Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitors
10. 8558002 - Sulfoximines as kinase inhibitors
11. 8455535 - Heteroaryl dihydroindolones as kinase inhibitors
12. 8455656 - Kinase inhibitors
13. 8455529 - Kinase inhibitors
14. 8383825 - Kinase inhibitors
15. 8338415 - Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitors